Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_Sales_Revenues_June_2024_espi.pdfSales revenues for June 2024

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 76 / 2024
Date of issue: 2024-07-22
Short name of the issuer
SOPHARMA AD
Subject
Sales revenues for June 2024
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that for June 2024 the Company recorded a decrease in sales of 35% compared to the same month of the previous year, incl. 7% decrease in domestic sales and 49% decrease in export sales.
Annexes
File Description
SFA_Sales_Revenues_June_2024_espi.pdf
SFA_Sales_Revenues_June_2024_espi.pdf		 Sales revenues for June 2024

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-07-22 Ognian Donev Executive director
20240722_130637_0229772213_SFA_Sales_Revenues_June_2024_espi.pdf

Pobierz